FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4320714922> ?p ?o ?g. }

• W4320714922 endingPage "1929" @default.
• W4320714922 startingPage "1917" @default.
• W4320714922 abstract "To develop an isotope dilution-liquid chromatography-tandem mass spectrometry-(ID-LC-MS/MS)-based candidate reference measurement procedure (RMP) for quantification of methotrexate in human serum and plasma.Quantitative nuclear magnetic resonance (qNMR) was used to determine absolute methotrexate content in the standard. Separation was achieved on a biphenyl reversed-phase analytical column with mobile phases based on water and acetonitrile, both containing 0.1% formic acid. Sample preparation included protein precipitation in combination with high sample dilution, and method validation according to current guidelines. The following were assessed: selectivity (using analyte-spiked samples, and relevant structural-related compounds and interferences); specificity and matrix effects (via post-column infusion and comparison of human matrix vs. neat samples); precision and accuracy (in a five-day validation analysis). RMP results were compared between two independent laboratories. Measurement uncertainty was evaluated according to current guidelines.The RMP separated methotrexate from potentially interfering compounds and enabled measurement over a calibration range of 7.200-5,700 ng/mL (0.01584-12.54 μmol/L), with no evidence of matrix effects. All pre-defined acceptance criteria were met; intermediate precision was ≤4.3% and repeatability 1.5-2.1% for all analyte concentrations. Bias was -3.0 to 2.1% for samples within the measuring range and 0.8-4.5% for diluted samples, independent of the sample matrix. RMP results equivalence was demonstrated between two independent laboratories (Pearson correlation coefficient 0.997). Expanded measurement uncertainty of target value-assigned samples was ≤3.4%.This ID-LC-MS/MS-based approach provides a candidate RMP for methotrexate quantification. Traceability of methotrexate standard and the LC-MS/MS platform were assured by qNMR assessment and extensive method validation." @default.
• W4320714922 created "2023-02-15" @default.
• W4320714922 creator A5001522570 @default.
• W4320714922 creator A5006139509 @default.
• W4320714922 creator A5012104172 @default.
• W4320714922 creator A5017477249 @default.
• W4320714922 creator A5029150766 @default.
• W4320714922 creator A5040667282 @default.
• W4320714922 creator A5045764553 @default.
• W4320714922 creator A5051065421 @default.
• W4320714922 creator A5062066440 @default.
• W4320714922 creator A5064135300 @default.
• W4320714922 creator A5065846385 @default.
• W4320714922 creator A5080869942 @default.
• W4320714922 creator A5087293182 @default.
• W4320714922 date "2023-02-15" @default.
• W4320714922 modified "2023-10-09" @default.
• W4320714922 title "An isotope dilution-liquid chromatography-tandem mass spectrometry (ID-LC-MS/MS)-based candidate reference measurement procedure (RMP) for the quantification of methotrexate in human serum and plasma" @default.
• W4320714922 cites W1607777623 @default.
• W4320714922 cites W1965049677 @default.
• W4320714922 cites W1982585544 @default.
• W4320714922 cites W1984336617 @default.
• W4320714922 cites W1985407376 @default.
• W4320714922 cites W2021276267 @default.
• W4320714922 cites W2025342209 @default.
• W4320714922 cites W2044624443 @default.
• W4320714922 cites W2050226999 @default.
• W4320714922 cites W2053931529 @default.
• W4320714922 cites W2061058995 @default.
• W4320714922 cites W2069310175 @default.
• W4320714922 cites W2080946738 @default.
• W4320714922 cites W2135478504 @default.
• W4320714922 cites W2216452883 @default.
• W4320714922 cites W2319813833 @default.
• W4320714922 cites W2493103431 @default.
• W4320714922 cites W2529756623 @default.
• W4320714922 cites W2530540225 @default.
• W4320714922 cites W2541074540 @default.
• W4320714922 cites W2772314164 @default.
• W4320714922 cites W2789480986 @default.
• W4320714922 cites W2949720741 @default.
• W4320714922 cites W2949724286 @default.
• W4320714922 cites W3012521674 @default.
• W4320714922 cites W3024378081 @default.
• W4320714922 cites W3119247864 @default.
• W4320714922 cites W3134889021 @default.
• W4320714922 cites W3168641095 @default.
• W4320714922 cites W3188862121 @default.
• W4320714922 cites W4213029709 @default.
• W4320714922 cites W4313857643 @default.
• W4320714922 cites W4360605055 @default.
• W4320714922 cites W2913400948 @default.
• W4320714922 doi "https://doi.org/10.1515/cclm-2022-1001" @default.
• W4320714922 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36788118" @default.
• W4320714922 hasPublicationYear "2023" @default.
• W4320714922 type Work @default.
• W4320714922 citedByCount "3" @default.
• W4320714922 countsByYear W43207149222023 @default.
• W4320714922 crossrefType "journal-article" @default.
• W4320714922 hasAuthorship W4320714922A5001522570 @default.
• W4320714922 hasAuthorship W4320714922A5006139509 @default.
• W4320714922 hasAuthorship W4320714922A5012104172 @default.
• W4320714922 hasAuthorship W4320714922A5017477249 @default.
• W4320714922 hasAuthorship W4320714922A5029150766 @default.
• W4320714922 hasAuthorship W4320714922A5040667282 @default.
• W4320714922 hasAuthorship W4320714922A5045764553 @default.
• W4320714922 hasAuthorship W4320714922A5051065421 @default.
• W4320714922 hasAuthorship W4320714922A5062066440 @default.
• W4320714922 hasAuthorship W4320714922A5064135300 @default.
• W4320714922 hasAuthorship W4320714922A5065846385 @default.
• W4320714922 hasAuthorship W4320714922A5080869942 @default.
• W4320714922 hasAuthorship W4320714922A5087293182 @default.
• W4320714922 hasBestOaLocation W43207149221 @default.
• W4320714922 hasConcept C10390740 @default.
• W4320714922 hasConcept C106487976 @default.
• W4320714922 hasConcept C113196181 @default.
• W4320714922 hasConcept C154020017 @default.
• W4320714922 hasConcept C162356407 @default.
• W4320714922 hasConcept C171679685 @default.
• W4320714922 hasConcept C185592680 @default.
• W4320714922 hasConcept C2777379063 @default.
• W4320714922 hasConcept C2778576202 @default.
• W4320714922 hasConcept C31827203 @default.
• W4320714922 hasConcept C43617362 @default.
• W4320714922 hasConcept C64489805 @default.
• W4320714922 hasConcept C74774607 @default.
• W4320714922 hasConceptScore W4320714922C10390740 @default.
• W4320714922 hasConceptScore W4320714922C106487976 @default.
• W4320714922 hasConceptScore W4320714922C113196181 @default.
• W4320714922 hasConceptScore W4320714922C154020017 @default.
• W4320714922 hasConceptScore W4320714922C162356407 @default.
• W4320714922 hasConceptScore W4320714922C171679685 @default.
• W4320714922 hasConceptScore W4320714922C185592680 @default.
• W4320714922 hasConceptScore W4320714922C2777379063 @default.
• W4320714922 hasConceptScore W4320714922C2778576202 @default.
• W4320714922 hasConceptScore W4320714922C31827203 @default.
• W4320714922 hasConceptScore W4320714922C43617362 @default.
• W4320714922 hasConceptScore W4320714922C64489805 @default.

• next